Your Leading Source of Intelligence into the Business of Biotechnology

GEN Edge is biotech’s leading source of business, science, and company news, including emerging research and drug discovery technologies impacting new therapeutic development and investment decisions. Our team of talented GEN Edge reporters deliver deep market intelligence and engaging thought leader interviews with biotech Movers and Shakers that go beyond the headlines to give you early insights into how, when, and why the latest developments are driving the future of the biotech industry.

GEN Edge subscribers across corporate and academic life sciences use our compelling editorial stories to maintain a competitive advantage and make informed business decisions that lead their organizations to innovation and success.

A subscription with GEN Edge grants you insider access to a host of subscriber-only content including breaking news, in-depth reporting, broadcast shows, video series, profiles of groundbreaking companies, market analyses, and access to live events.

Unlock Premium Subscriber Benefits



For only $18 a month*, GEN Edge delivers:

INSIGHTS FROM INDUSTRY LEADERS Exclusive Interviews with Close to the Edge and Front Row

Experience in-depth interviews with high-profile biotech newsmakers and CEOs in critical areas of science, medicine, and biotechnology. Hear firsthand conversations spotlighting the current and next generation of biotech leaders on crucial topics like Alzheimer’s disease and AI for drug discovery.

INTEL ON THE BUSINESS OF BIOTECH Premier GEN Edge Live Series

Engage in thought-provoking and critical conversations with leading financial analysts and commentators on the business of the biotech industry. Experts discuss timely stock trends, innovations, challenges confronting the industry, and more.



UPDATES FROM THE FOREFRONT In-depth Stories, News Alerts, Stock Watch, and more.

Go on the record with GEN Edge and groundbreaking companies in biotech. Get the scoop on business developments, investments, acquisitions, takeovers, breakout startups, partnerships, patent disputes, regulatory filings, and more. Tune in to interviews with CEOs, founders, KOLs, and other newsmakers on what makes the industry tick.

YOUR COMPETITIVE EDGE Free Pass to Focused Industry Events

Velvet rope access to attend and network at special events like the GEN Edge’s State of Biotechnology Virtual Summit in September, featuring Nobel Prize Winner Jennifer Doudna, infectious disease thought leader Peter Hotez, and many more!


ACCESSIBILITY AT YOUR FINGERTIPS Access to the Entire GEN Edge Archive

Make decisions confidently through more than 300 GEN Edge data-rich resources like originally reported news, stories, and interviews, including embargoed access to A-Lists exclusive list of top drugs, companies, and biotech clusters.


COVERAGE FROM EXPERT CONTRIBUTORS Reporting on the Full Biotech Spectrum

Hear from our GEN Edge industry experts who have their fingers tapped deeply into the pulse of biotechnology. Be in the know with our writers and reporters, who cover the entire spectrum of biotech business to emerging technologies and investments shaping tomorrow’s medical breakthroughs. Learn more about the GEN Edge Contributor Team here.

FREQUENTLY ASKED QUESTIONS

Wondering how the 30-day free trial works? Does GEN Edge offer group membership? What is our cancellation policy? Visit our FAQ page to learn more.

*With an annual subscription.

Copyright © 2022 Genetic Engineering & Biotechnology News. All Rights Reserved.